Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cocrystal Pharma Inc. logo

Cocrystal Pharma Inc.

Sector: Healthcare   

Industry: Biotechnology

1.40
 
USD
  
-0.10
  
(-6.67%)
Optionable: No  Market Cap: 15 M  90-day average vol: 12,970

Previous close: 1.5  Open: 1.53  Bid: 1.38  Ask: 1.72
52 week range    
1.33   
   3.29
Peers   
MRK / 
NATR / 
JNJ / 
TENX / 
Last updated: Friday 29th March 2024
43
MarketXLS Rank
60
Value
38
Technical
31
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58

NATR

0 B16.817.8

TENX

0 B-0.30.7312

USNA

2 B14.693.09
Financials

COCP Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends-4 M
AcquiredInProcessRnD256000.0
AcquiredInProcessRnDIncome-12 M
Amortization of intangibles19 M19 M
Basic EPS from continuing operations-2.04-1.92-4.77
Basic EPS total-3.96-0.96-1.32-0.36-2.04-1.92-4.77
Basic weighted shares outstanding5 M27233.052526.059 M2 M2 M2654.04601.07 M8 M
Depreciation157000.0190000.0185000.0
Depreciation unreconciled-50000.0-98000.0
DepreciationAndAmortization-50000.0-98000.0157000.0190000.0185000.0
Diluted EPS total-1.32-0.12-0.96-1.32-0.36-21.0-18.12-2.04-1.92-4.77
Diluted normalized net income/share-18.12
Diluted weighted shares outstanding6 M27312.052526.059 M2 M2 M2654.04601.07 M8 M
Earnings from equity interest-4 M306000.0
EarningsFromEquityInterestNetOfTax-4 M306000.0
GainOnSaleOfPPE-1 M-584000.0-2 M-100000.0-60000.0
GainOnSaleOfSecurity192000.07 M-10 M3 M-54000.049000.0-6000.0
GainsLossOnDisposalOfDiscontinuedOperations-9 M
GeneralAndAdministrativeExpense219000.02 M7 M4 M2 M4 M5 M6 M5 M6 M
Gross operating profit9000.078000.0907000.07 M2 M
ImpairmentOfCapitalAssets-92 M54 M46 M19 M
Income before tax-4 M-151000.0-65 M-104 M-7 M-63 M-48 M-10 M-14 M-39 M
Income taxes1 M-52000.0-15 M-29 M-7 M-14 M14 M
Interest income-151000.0-65 M-1 M306000.0
InterestExpenseNonOperating-3 M19000.08000.04000.02000.0
InterestIncomeOperating2000.096000.0180000.03 M-7000.0
MiscOtherSpecialCharges-946000.0-762000.0-152000.0106000.0
Net income from total operations-8 M137000.0-115 M-75 M-613000.0-49 M-48 M-10 M-14 M-39 M
NetIncomeCommonStockholders-8 M137000.0-115 M-75 M-613000.0-49 M-48 M-10 M-14 M-39 M
NetIncomeContinuousOperations-8 M137000.0-115 M-75 M-613000.0-49 M-48 M-10 M-14 M-39 M
NetIncomeDiscontinuousOperations-9 M
NetNonOperatingInterestIncomeExpense3 M-151000.0-65 M-1 M306000.0-19000.0-8000.0-4000.0-2000.0
NetOperatingInterestIncomeExpense-7000.0-58000.0
Normalized income-11 M-9 M
Operating income-4 M-6 M-54 M-106 M-8 M-9 M-2 M-10 M-14 M-18 M
Operating income before depreciation (EBITDA)-4 M48000.0-65 M-104 M-7 M-63 M-48 M-9 M-14 M-35 M
OperatingExpense-4 M-6 M-54 M-106 M-8 M-63 M9 M12 M14 M-18 M
Other income net4 M-6 M12 M762000.0-807000.0-46000.054000.0-49000.021 M
OtherGandA219000.02 M7 M4 M2 M4 M5 M6 M5 M6 M
OtherOperatingExpenses7000.01000.031000.0-63 M-55 M12 M14 M-2 M
OtherunderPreferredStockDividend-4 M
PreferredStockDividends-4 M
RentAndLandingFees219000.02 M7 M4 M2 M4 M
Research & development expense4 M4 M47 M102 M6 M5 M4 M6 M9 M12 M
ResearchExpense4 M4 M47 M102 M6 M5 M4 M6 M9 M12 M
Revenue per share-156000.020 M19 M592000.0
SalariesAndWages-371868.0-562000.0-351000.0
Selling Gen & administrative expense219000.02 M7 M4 M2 M4 M5 M6 M5 M6 M
Special income/charges92 M-54 M-46 M-21 M
Total Income available for interest expense (EBIT)-4 M-151000.0-65 M-104 M-7 M-63 M-48 M-10 M-14 M-36 M
Total common shares outstanding334723.02 M2 M2 M67777.03 M4 M6 M8 M8 M
Total net income-8 M137000.0-115 M-75 M-613000.0-49 M-48 M-10 M-14 M-39 M
Total ordinary shares10 M10 M10 M10 M10 M10 M10 M10 M10 M10 M
Total revenues9000.078000.0907000.07 M2 M
TotalExpenses-4 M-6 M-54 M-106 M-8 M-63 M9 M12 M14 M39 M
TotalRevenue9000.078000.0907000.07 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University